- Home
- Cardiovascular News
Cardiovascular News
Please find all MAQUET related press releases below. For additional information, please contact us.
Getinge acquires US company Atrium Medical Inc.
-
October 3, 2011 - Getinge to expand within cardiovascular area through acquisition of US company Atrium Medical Inc.
MAQUET Receives EACTS Techno College Innovation Award
-
Wayne, N.J. - October 3, 2011 - MAQUET, a global leader in medical systems, today announced that the company has received the 2011 European Association of Cardio-Thoracic Surgery (EACTS) Techno College Innovation Award for its revolutionary CARDIOHELP System. Approved for use in the United States and Europe, CARDIOHELP is the world's smallest portable heart-lung support system providing extracorporeal life support to replace or support a patient's circulation and respiration. It is the first portable, lightweight device of its kind, and the first support system that can be used for both land and air transportation.
FDA 510(K) Clearance & CE Mark For SENSATION PLUS™ IAB...
-
Mahwah, N.J. - September 20, 2011 - MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval from the British Standards Institution (BSi) for its new SENSATION PLUSTM 50cc 8 Fr. intra-aortic balloon catheter. The new SENATION PLUS intra- aortic balloon (IAB) catheter is the first 50cc 8 Fr. IAB catheter to combine fiber optic signal acquisition with greater hemodynamic support compared to a standard 40cc IAB catheter.
Trial Comparing Use Of MAQUET Pressure Controlling Syringe to...
-
Wayne, N.J. - June 10, 2011 - MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of a new prospective trial that is designed to compare the endothelial function of saphenous vein grafts using the MAQUET VASOSHIELD Pressure Controlling Syringe with graft preparation methods using a standard syringe in patients undergoing coronary artery bypass graft (CABG) surgery.
510(K) Clearance To Market CARDIOROOT Aortic Graft In U.S.
-
Wayne, N.J. - May 19, 2011 - MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOROOT aortic graft in the U.S. An innovative, one-piece design, aortic root graft, CARDIOROOT will be used by vascular and cardiovascular surgeons to surgically repair or replace diseased and damaged aortae. CARDIOROOT is now commercially available in the U.S.
MAQUET Announces U.S. Launch of VASOVIEW 6 PRO Endoscopic Vessel...
-
Wayne, N.J. - February 9, 2011 - MAQUET Cardiovascular today announced the U.S. launch of the VASOVIEW 6 PRO Endoscopic Vessel Harvesting System. This latest advance in the VASOVIEW 6 platform for endoscopic vessel harvesting (EVH) offers streamlined controls, improved functionality and simplified operation to support positive outcomes in delivering EVH to patients undergoing cardiac surgery.
MAQUET Announces U.S. Launch of New ACROBAT-i Off-Pump System...
-
Wayne, NJ - January 31, 2011 - MAQUET Cardiovascular today launched its new ACROBAT-i Stabilizer and Positioner System at the Society of Thoracic Surgery Meeting in San Diego. Developed for use in performing off- pump coronary artery bypass (OPCAB) procedures on coronary artery bypass graft (CABG) patients, this next-generation ACROBAT-i System, the latest in the ACROBAT family, has a significantly lower profile design and tubing management features that allow increased access to and visibility of the surgical field.
Press Release: HYBRID OR MEDICA consumer press
-
Rastatt, Germany - November 2010 - The first thing a layperson associates with the term “hybrid” is the car. The hybrid car has an internal combustion engine as well as an electric motor with an energy storage device. In numerous other technologies "from clock to hard drive", this term also describes the pooling of several positive features for the benefit of the user. In the case of the hybrid operating theater, patients are the ones who benefit most, followed by physicians and hospitals.
Press Release: HYBRID OR MEDICA trade press
-
Rastatt, Germany - October 2010 - “You must not fool yourself – this is a big project in need of a lot of coordination”, describes Andreas Lauinger, technical director and authorized signatory for the Heart Surgery Clinic in Karlsruhe, his experience with the construction of the local hybrid OR. The implementation in Karlsruhe only took 15 months which shows that the project coordination was well thought through. The hybrid OR - in this case a synthesis of operating theater for heart surgery and fully equipped cardiac catheter laboratory – is a highly complex structure, considering the planning and technical process.
Press Release: MEDICA Show consumer press
-
Rastatt, Germany - October 2010 - It is the heart itself which sets the rhythm for Maquet’s presentation in Hall 12, Stand 50/51: Its “da-dam” on a darkened stage leads us at a stroke right into the topic. This sound is joined by other heart rhythms until the visitor is acoustically enveloped by the event. This impression of being “right at the heart of things rather than just a spectator” is achieved with the second main theme, lung therapies, thanks to the use of breathing sounds.
Maquet Cardiovascular Announces Availability Of Best Practices...
-
Wayne, NJ - October 4, 2010 - MAQUET Cardiovascular today announced the availability of a ”Golden Rules” whitepaper documenting endoscopic vessel harvesting (EVH) best practices. EVH is a minimally invasive technique widely used during coronary artery bypass graft (CABG) surgery to remove a vessel from the leg or arm of a patient that is then used as conduit by bypassing blockages. The paper highlights the value EVH provides patients, and consolidates the vast scientific experience, knowledge and learnings from a network of well-seasoned harvesters into one state-of-the-art summary.
Press Release: Maquet Cardiovascular Announces Enrollment Of...
-
Wayne, NJ - September 22, 2010 - MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.
Maquet Cardiopulmonary Ag Announces Board Of Directors Change
-
Hirrlingen, Germany - September 9, 2010 - MAQUET Cardiopulmonary AG recently announced that Wolfgang Rencken, Phd, has assumed the role as new President/ CEO at MAQUET Cardiopulmonary AG, the world’s leading manufacturer of heart-lung-support systems.
MAQUET Cardiovascular Launches Advanced VASOVIEW Technology In...
-
Wayne, N.J. - July 26, 2010 - MAQUET Cardiovascular today announced the launch of its VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System, which utilizes next-generation HEMOPRO cut-and-seal technology to reduce thermal spread and to achieve optimal conduit quality for coronary artery bypass graft (CABG) surgery patients. The minimally invasive VASOVIEW HEMOPRO 2 system is an example of MAQUET Cardiovascular’s commitment to EVH, and technologies that promote the highest level of conduit quality.
Datascope InterVascular is now MAQUET Vascular Interventions.
-
MAQUET provides full support to cardiac, cardiothoracic, and vascular surgeons and their teams that perform cardiothoracic, abdominal aneurysm, and peripheral vascular repair.